Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

FDA IND approval for Phase 2b trial in brain metastases

Tuesday, July 23, 2024 1 min read
Key Takeaway: Radiopharm Theranostics has received FDA IND approval to initiate a Phase 2b clinical trial targeting brain metastases. This approval marks a crucial step in advancing their therapeutic approach. The trial aims to evaluate the efficacy and safety of their treatment in patients with this challenging condition.

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA IND approval for Phase 2b trial is a significant milestone.
  • The trial targets brain metastases, addressing a critical medical need.

Full Press Release Details

• Announcements
• Price Sensitive
• July 23, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• March 26, 2024
• Announcements
• September 20, 2022
• Announcements
• November 29, 2022
• Announcements
• May 9, 2023

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What trial did Radiopharm Theranostics receive FDA approval for?

Radiopharm Theranostics received FDA IND approval for a Phase 2b trial.

What condition is the Phase 2b trial targeting?

The trial targets brain metastases.

What is the significance of the FDA approval?

The FDA approval is a crucial milestone for advancing treatment options.

Tags: RADX Viatris Investor Conferences Healthcare FDA approval Phase 2b trial brain metastases Radiopharm Theranostics
Last updated: Jul 23, 2024